Contemporary Overview of Blood Concentrates in Oral and Maxillacial Surgery by Gönül, Onur et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Contemporary Overview of 
Blood Concentrates in Oral and 
Maxillacial Surgery
Onur Gönül, Ahmet Usame Çiçek, Murat Afat, 
Onur Atalı and Faysal Uğurlu
Abstract
It has always been a target to shorten and improve the healing process in 
medical field. Platelets with cytokines and growth factors in their structure have 
great importance on wound healing. Features of platelets gave the clinicians the 
idea of using platelet concentrates to promote the healing process. For this reason, 
many platelet-derived biomaterials have been tried in the medical field over the 
years. When approaching today, platelet concentrates have been found to be used 
medically, especially with the use of platelet rich plasmas (PRPs) and then platelet 
rich fibrins (PRFs). In particular, several studies conducted in recent years have 
revaled different blood concentrates. This chapter summarizes the develoment 
over time, properties and usage areas of blood concentrates in dentistry.
Keywords: platelet rich fibrin, platelet rich plasma, sinus lifting, growth factor, graft, 
regeneration, oral and maxillofacial surgery
1. Introductıon
Platelets are the smallest, colorless blood cells which paly a majör role ın coagu-
lation cascade and prevent excessive blood loss. Plateletsb diameters varies between 
1-3 microns and they appear in a bright blue color under the microscope. Low 
platelet rate causes an increase in the tendency to bleed, and high platelet rate causes 
a clot (thrombosis) formation in the vein [1].
Platelets provide their functions with secretory granules in which there is a 
reservoir in its structure and freshly synthesized mediators. These granules consists 
ATP, ADP, serotonin, fibrinogen, plasminogen, platelet derived growth factor 
(PDGF), transforming growth factor beta (TGF-β), vascular endothelial growth 
factor (VEGF), epidermal growth factor (EGF), insulin like growth factor (IGF), 
etc. The growth factors have stimulating effect on wound healing by means of 
potential for matrix remodeling, cell proliferation and angiogenesis [2, 3].
Accordong to several researches, main task of platelets in the body is hemostasis 
and final clot formation in bleeding areas. In addition to their hemostatic duties, 
they are also effective in the tissue repair process due to the long term effects of 
these growth factors in theri structure [2, 3].
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Platelets are counted among the potential cells of regenerative therapy. For the 
fact that they consist a large number of growth factors and are easy to obtain, has 
increased the interest in platelets. Tissue regeneration enginering is a field that 
many studies and attempts have been made about repairing a diseased tissue, regen-
erating or restoring a damaged tissue. Initially, studies have included allografts, 
xenografts, synthetic-based alloplasts, etc. However, most of these materials were 
observed to cause foreign body reaction in the body, which lead the studies to the 
human bodys’s own tissues [4–7].
Ideas based on the use of human blood proteins as sources for regeneration arise 
from the idea that blood-derived proteins are a source of growth factors that can 
support angiogenesis and tissue growth for tissue regeneration. The healing process 
required for regeneration consists of hemostasis, inflammation, proliferation and 
maturation phases. Each phase requires its own specific proteins and cell types. 
However, since the non-human biomaterials used are avascular, the use of blood 
concentrates becomes more prominent [4–7].
As mentioned earlier, wound healing is a process that occurs as a result of hemo-
stasis, inflammation, proliferation and maturation phases. Platelets are essential 
components that play an active role in the stages of hemostasis and fibrin forma-
tion, that is, in the early phases of the tissue regeneration process. Platelets secrete 
and contain some growth factors such as PDGF (Platelet derived growth factor), 
VEGF (Vascular endothelial growth factor), cytokines, etc., as well as angiogenetic 
factors that stimulate proliferation and activate the wound healing cells such as 
fibroblasts, neutrophils and mesenchymal stem cells [3, 8].
2. History of blood concentrates
The use of blood concentrates in medical field for various purposes is common 
for a long period of time. When we look at its historical background, the idea was 
used in the 1970s to be used for nerve tissue repair. The first use of platelet-rich 
plasma was reported in 1987 by Ferrari et al. during cardiac surgery and PRP was 
used to repair damaged cardiovascular tissues [9].
Looking at its use in dentistry, in the late 1990s, Whitman et al. suggested using 
PRP in oral surgical procedures, observing that PRP enhanced osteoprogenitor cells 
in bone graft and bone tissue. However, it is reported that depending on the use of 
bovine thrombin, coagulopathies and immune reactions can be observed [9, 10].
PRF is considered as the current platelet concentrate and has been used in oral 
and maxillofacial surgery since 2001. Accordıng to Choukroun et al. who first 
described PRFs in literature, PRFs have some advantages compared to PRPs, such as 
easier preparation and no chemical intervention to blood concentrates [11].
According to leukocyte and fibrin content, Verma et al. divided the platelet 
concentrates into 4 basic categories. They categorized platelet concentrates as 
P-PRP, L-PRP, P-PRF, and L-PRF [12].
Choukroun, the first person to report the use of PRF in 2001, described A-PRF, 
a new form of PRF, containing higher amounts of leukocytes in 2014. According to 
Choukroun, this new type of PRF has more potential than the original PRF [13].
3. Classıfıcatıon of blood concentrates
The story of blood concentrates is usually examined in 2 parts/generations. 
Here we see the PRPs first, and the PRFs as the second generation. Classification is 
simply done as follows:
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• P-PRP (1. GENERATION)
• L-PRP (1. GENERATION)
• P-PRF (2. GENERATION)
• L-PRF (2. GENERATION)
• I-PRF (2. GENERATION)
• A-PRF (2. GENERATION)
• T-PRF (2 GENERATION)
4. Preparation procedures and clınıcal features of PRPs
Basically, the aim of the formation of blood concentrates is to achieve higher 
platelet density and high level of growth hormones. PRPs are also tried to be pre-
pared for this purpose. PRPs are basically condensed plasma with a higher platelet 
concentration than the normal state of the blood. PRPs show high platelet and 
growth factor levels compared to normal blood. It has been determined that PRPs 
have positive effects on periodontal cells, osteoblasts, etc. after their use [9, 14–18].
Despite their benefits, PRPs have some disadvantages. They are obtained in a 
multi-stage and long process, difficult to handle and expensive to obtain. PRPs 
usually have two basic centrifuge steps. Ethylenediaminetetraacetic acid (EDTA) 
or citric acid can be used in the first slow centrifuge step. Then comes the second 
centrifuge step, which is applied faster. At this stage, additional substances such 
as calcium chloride or/and bovine thrombin can be used. These additives, in fact, 
cause blood concentrates, which are of interest as being autologous, to loose their 
full autologous feature. In addition, foreign substances -especially bovine thrombin- 
which are included in the PRPs, increase the potential of PRPs to create a foreign 
body reaction. Accordingly, the natural inflammatory process of the body can be dis-
rupted. In addition, artificial clotting is provided while obtaining PRP. Accordingly, 
the fibrin matrix structure formed is different from the structure obtained naturally. 
The fibrin matrix structure obtained in this way is more rigid. Due to this rigid struc-
ture, it does not release the growth factors in the PRP in a controlled and long term 
and releases all at once. Also bovine thrombin can cause the risk of coagulopathy as 
well as foreign body reaction. It also increases the cost of preparing PRPs with special 
kits and spending a lot of time. PRPs are often used by mixing with grafts due to the 
disadvantage of their liquid structures during use [9, 14–18].
5. Preparation procedures and clınıcal features of PRFs
Despite the high platelet and growth factor ratios provided by PRPs, the 
observed negativities pushed clinicians to new researches. As a result, PRFs, which 
are the second generation blood concentrates and have the advantages of being 
prepared more quickly, have emerged. PRFs appeared mainly as blood concentrates 
created without using additive anticoagulants. A single, high-speed return is 
achieved in obtaining the PRF. In the most basic centrifuge method that provides 
the PRFs, single centrifugation is performed for 12 minutes at 2700-3000 rpm per 
minute [4, 19–23].
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In this way, three layers are obtained:
• Protein Poor Plasma (PPP)
• Platelet Rich Fibrin (PRF)
• Red Blood Cells (RBC)
As studies based on PRF progressed, it was understood that the amount of 
leukocytes in the content had an important effect on ideal wound healing. This is 
the reason why leukocyte content is also taken into account in the classification 
of PRFs. The presence of leukocytes has been found to be effective in obtaining 
clinical results ideally and achieving lower infection rates. PRFs are structures 
that contain important cells for healing process of the body, but it is also impor-
tant that they form a three-dimensional matrix and contain significant growth 
factors [4, 12, 19–23].
PRFs, of course, did not remain as they first appeared, but were developed in 
time. PRFs with different contents were obtained by applying different centrifuge 
methods. The first obtained P-PRF consisted of a solid fibrin matrix structure and 
did not contain leukocytes. Later, L-PRF appeared, known as leukocyte and platelet-
rich fibrin. The A-PRFs were produced by Choukroun, the first revealer of PRFs. 
This type of PRF has a better handling than other types of PRFs. It is obtained by low 
speed centrifuge. 14-minute centrifuge process at 1500 rpm is required for the A-PRF 
acquisition. A-PRFs are blood concentrates containing high amounts of leukocytes. 
In addition, I-PRFs, an injectable form of PRFs, have emerged. I-PRFs are a type of 
PRF that can also contain stem cells. To obtain it, centrifuge should be applied for 
3-4 minutes at 800 rpm. Another type of PRF is T-PRF. The main difference is that 
Figure 1. 
PRF clot just after centrifuge.
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the tubes are made of titanium. According to some studies fibrin matrix obtained in 
this method is considered to be more successful (Figures 1 and 2) [4, 12, 19–23].
PRFs have been of great interest and improved platelet concentrates for many 
years. The reason for this is of course their advantages. Unlike the PRPs we men-
tioned earlier, PRFs are produced completely autogenously. There is no need for 
extra biochemical interventions. It has an easy application procedure. The method 
is inexpensive since there is no kit requirement or extra process requirement 
mentioned in PRPs. Since there is no substance added from the outside, fibrinogen 
turns into fibrin thanks to the thrombin that is found in the blood spontaneously. 
In this way, the mechanism operates slowly and in accordance with its natural state. 
The fibrin thus formed is also a close to nature fibrin. Cell migration and prolifera-
tion increased compared to PRP. There are studies showing that it positively affects 
osteoblast activity. Also, when compared with PRP, it is seen that PRFs have higher 
fibrin content [4, 19–23].
In addition to the many advantageous features described, PRFs also have some 
disadvantages. Blood is required to be applied. This situation creates anxiety in 
patients or increases the tendency to refuse treatment. When it is desired to obtain 
high amounts of PRF, serious blood intake is needed. There is a need for a glass-
coated tube to perform the process [19–23].
6. Applıcatıon fıelds ın dentıstry
PRFs have been used in many fields of medicine and dentistry since its occur-
rence. It is used in general medicine especially in orthopedic field and for the 
healing of open wounds and ulcers. In dentistry, it is used in endodontics, peri-
odontology and oral and maxillofacial surgery. Main fields of clinical usage are 
given below [4, 19–23].
ENDODONTICS:
• Can be used for pulp regeneration
• It can be used for apex formation procedures.
• It can be used in the treatment of periapical cysts.
Figure 2. 
PRF membrane after pressing PRF clot between two sterile surfaces.
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• Can be used as a pulp capping material.
PERIODONTOLOGY:
• It is used to treat intrabony defects.
• It is used to stimulate wound healing after periodontal surgery.
• For coverage of open root surfaces
ORAL and MAXILLOFACIAL SURGERY:
• It is used to protect the socket.
• It is used to prevent alveolitis.
• It is used to ensure the ideal healing of the area after apical surgery.
• It is applied to the peri-implant region to support osseointegration.
• It is used in grafting procedures in bone deficiencies.
• Can be used with or without grafts in sinus lifting procedures.
• It can be used to accelerate recovery after surgery for osteonecrosis.
• It can be used as matrix in biomaterial applications.
7. Biologıcal vıew of PRFs
Understanding the biological properties of PRFs depends on having informa-
tion about the content. Also, it is important to know the wound healing process to 
understand the effects of PRF. The healing of wounds is a process that starts with 
the hemostasis mechanism and continues with a series of events. The effect of PRFs 
depends on some key features. The first is the presence of the fibrin matrix. In this 
way, the fibrin matrix acts as a scaffolding where the cells providing the construc-
tion events migrate. The second is the fibrin matrix and the cells in it; secrete 
chemotactic proteins, cytokines and growth factors. The third is that the fibrin 
matrix and its factors induce vascular structure formation [4].
The effects of PRFs come from the elements in it. Its structure consists of fibrin 
matrix and cellular elements. The most important cell in its structure as a cellular 
element is of course platelets. In addition, its structure includes leukocytes, neutro-
phils, monocytes and mesenchymal stem cells. Growth factors, which are considered 
as the most important content of PRFs, are secreted by other cellular elements, 
especially platelets. The secretion of growth factors and their functions are very 
important for the functions of PRFs [4].
We know that PRFs provide secretion of many growth factors. These factors and 
effects are given below;
• TGF-β1: This molecule is an important inflammation regulator. It is also a 
very strong fibrosis agent. Its most important tasks are tissue repair, immune 
modulation and extracellular matrix synthesis. In addition, TGF-β1 plays an 
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important role in collagen production. TGF-β1 also plays a role in restoring 
epithelialization and connective tissue healing. Transforming growth factor 
beta is also a critical mediator for bone formation. It stimulates the chemotaxis, 
cleavage and accumulation of osteoblasts [4, 24–26].
• PDGF: This growth factor known as platelet derived growth factor is important 
for the proliferation, migration and survival of mesenchymal cells. This growth 
factor also enables extracellular matrix production to occur during tissue healing. 
He is also involved in collagen production-demolition mechanisms. PDGF is also 
a mitogen factor for osteoblast and fibroblast cells [4, 24–26].
• EGF: It stands for epidermal growth factor. The receptors of this factor are 
expressed in the majority of human cells, including cells that are important in 
wound healing stages. EGF stimulates the division of mesenchymal stem cells. 
It also provides chemotaxis in endothelial cells [4, 24–26].
• VEGF: Vascular endothelial growth factor is most commonly secreted by 
platelets and macrophages. This growth factor is the most active growth factor 
for vascular regeneration. It provides angiogenesis and the formation of new 
blood vessels. In this way, blood flow and thus nutrition increase in injured 
tissues [4, 24–26].
• IGF: Insulin-like growth factor is released when platelets are activated. It 
induces the differentiation and division of mesenchymal stem cells. IGF is also 
one of the mediators involved in the regulation of the programmed cell death 
process. Besides, IGF stimulates proliferation and differentiation in many cells 
of the body. IGF is also involved in bone matrix formation and replication of 
osteoblasts [4, 24–26].
8. Clınıcal applications ın maxıllofacıal surgery
8.1 Sınus lıftıng
The high healing potential and ingredients of the PRFs have brought to mind the 
ideas of both increasing the success and shortening the healing time by using them in 
sinus lifting procedures. Based on these ideas, PRFs were used in sinus lifting proce-
dures, firstly mixed with grafts and then without using grafts. In studies conducted, 
it has been observed that even though there are no large differences in the amount 
of bone tissue obtained as a result of mixing graft materials and PRFs, it accelerates 
the maturation and the wound healing period. In addition, using PRFs mixed with 
graft materials makes the manipulation of the graft material quite easy. In addition, 
when PRF membranes are used in sinus lifting procedures instead of other mem-
branes, PRF membranes have been found to be an inexpensive, easy-to-manipulate 
membrane, so they can be used to close lateral sinus Windows (Figure 3). When used 
for closing the lateral sinus window, it speeds up the healing process and provides 
good protection for the Schneiderian membrane (Figure 4). In cases where the 
Schneiderian membrane is perforated, PRF membranes are used to make a healing 
barrier for the perforation zone [27–31].
Although PRFs have the expectation of controlling tissue inflammation with 
their special biological properties and providing good vascularization in bone 
tissue, the studies conducted have not yet shown a common understanding of their 
effects in the literature [27–32].
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8.2 Alveolar socket preservatıon
Studies on PRF consider that the use of PRF accelerates epithelialization and 
vascularization so that wound healing takes place effectively and quickly. However, 
operations such as tooth extractions and cyst enucleations lead to bone defects 
after healing process. These defect areas creates esthetic and functional deficiency 
problems for patients. By using PRFs on healing processes, it has been thought that 
healing of intra-bony sockets in the alveolar area can be accelerated and bone defect 
formation can be reduced (Figure 5) [32–34].
Figure 4. 
Application of PRF as a membrane on sinus membrane.
Figure 3. 
Application of PRF as a bulk matrix for sinus lifting.
9Contemporary Overview of Blood Concentrates in Oral and Maxillacial Surgery
DOI: http://dx.doi.org/10.5772/intechopen.93865
There are studies that believe that PRFs inserted into the sockets do not make a 
significant difference in preventing complications in the post-operative period, as 
some studies show that there is a significant decrease in the frequency of occurrence 
of alveolar osteitis and bone loss in patients, especially after the 3rd molar surgery. In 
addition, it is seen that there is no definite opinion about bone gain and remodeling in 
the literature. However, it is possible to say that the use of PRF improves the patient 
experience by reducing the frequency of complications such as pain and swelling in 
the post-operative period. However, its cost is very low, making it attractive to use for 
post-operative socket protection [34–37].
8.3 Alveolar rıdge augmentatıons
The use of PRF draws attention in augmentation procedures in many fields. 
PRFs are used for more than one purpose in guided bone regeneration (GBR). PRFs 
can be used as membranes or preferred to speed up the wound healing process. 
Studies showed that PRF membranes are successful in closing bone defects. 
However, the use of PRFs as a barrier membrane in GBR processes alone creates a 
question. In addition, injecting PRFs into the region in liquid form or placing PRF 
membranes around the collagen membranes used can stimulate and accelerate soft 
tissue healing in the region (Figure 6). Besides, it can stimulate bone tissue healing. 
The use of PRF has the potential to increase bone vascularization in areas where 
GBR is performed. Also, mixing of PRFs with grafts increases the stability and 
manipulation potential of the grafts in augmentations (Figures 7–9) [38–41].
8.4 Implants and PRF
Marginal bone loss may occur following implantation. In order to repair or stop 
these bone losses, many studies have been performed over the years and different 
methods have been explained. The clinicians, who thought that marginal bone 
loss around the implant was completely caused by soft tissue quality and health, 
thought that PRFs, which are considered to be a very successful material when 
used in soft tissue augmentation, will completely stop marginal bone loss. There 
are also studies reporting that the use of PRF in defects around implants, the use of 
PRFs in flap operations and grafting procedures, yields better results than standard 
protocols. However, there are no definitive results in the literature regarding the 
effect of PRF use on hard tissue augmentation and it is stated that more studies are 
needed [42, 43].
Another area in which PRFs are used in relation to dental implants is their 
impact on implant stability. In studies conducted on this subject, the stability of 
the implants was measured by making early resonance frequency analyzes. In the 
Figure 5. 
Using PRF in the extraction socket.
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Figure 7. 
PRF with bone graft.
studies conducted, it is generally believed that the use of PRF increases the ISQ 
values of the implants in the early healing period [44–46].
Thanks to the cytokines it contains, it can be used to control inflammation in the 
inflammatory conditions around the implant as well as in the sockets. Besides, PRFs 
can be useful in increasing gingival quality and peri-implant periodontal tissue 
regeneration processes [44–46].
PRFs can be useful in immediate implantation situations where implantation 
will be performed immediately after extraction. The most important reason for this 
Figure 6. 
PRF membranes on the particulated xenografts grafts.
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are the growth factors and cytokines. Thanks to these substances, it will create a 
high healing potential. In addition, the gaps between the implant and the bone wall 
can be filled using PRF in immediate implantations. This can only be done by using 
PRF or by mixing PRF and bone graft materials. However, in cases using collagen 
membranes, the potential for soft tissue healing can be increased by using PRF 
(Figures 10–13) [47, 48].
Figure 9. 
Grafted area on the CBCCT after 6 months of application.
Figure 8. 
Alveolar ridge augmentation.
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Figure 11. 
Titanium mesh application for GBR.
8.5 PRF applıcatıons in other fıelds oral and maxıllofacıal surgery
In oral surgery practice, oroantral fistulas may occur due to the morphology 
of the region or due to iatrogenic reasons in the attempts made in the posterior 
maxilla. Oroantral fistula formation can often occur due to tooth extractions from 
the region, after cyst excisions or in relation to implant surgery. In the process of 
Figure 10. 
Deficient bone around implant.
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closing these fistulas, generally shifted flap techniques are used. However, in recent 
years, PRF has been used to close these defects. After the region is removed from 
infected tissues as in other techniques, PRF is applied to the area as thin mem-
branes. In this way, it is not necessary to use outsourced material or use techniques 
that create serious donor site morbidity [49–51].
Intraoral osteonecrosis scenarios appear due to various medical conditions, 
especially bisphosphonate group drugs. Generally, some studies in recent years 
have suggested the use of PRF in osteonecrosis cases, which is tried to be treated 
Figure 12. 
Application of graft material.
Figure 13. 
PRF insertion over Ti-mesh membrane.
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in various ways such as curettage, hyperbaric oxygen therapy, laser stimulations. It 
has been reported that PRF can act as a barrier membrane and accelerate soft tissue 
healing around the necrotic areas [52, 53].
PRFs can be used in the surgery of alveolar clefts apart from many other areas 
mentioned. In addition, it can be used to stimulate healing in patients who have or 
are likely to experience a healing problem due to medical problems [54].
9. PRF for endodontıcs
As a result of recent studies, regenerative endodontic therapies have begun to 
take their place among endodontics procedures. Regenerative procedures are mainly 
aimed at making the pulp functional by stimulating the pulp tissue that loses its 
function and cells with the potential for change in it [55, 56].
In the light of the studies, it was seen that PRFs can be used for regeneration in 
endodontics. For this purpose, in endodontics, PRF can be used for apex closure 
procedures and for revascularization procedures [55, 56].
In some of the studies conducted, PRF was used with MTA to manage the 
formation of apex. As a result, it was observed that beneficial results were obtained 
by using two materials together. The reason for the promising results obtained 
by using two materials together is that they work synergistically when they are 
together and thus stem cell and odontoblast stimulation is considered to be more 
successful [55–59].
Another area regarding the use of PRFs in endodontics is revascularization pro-
cedures. It is thought that PRFs can be used as scaffold material for regeneration of 
necrotic pulp and it is an ideal material as scaffold. The reason for this is, of course, 
the high amount of growth factors that PRF contains. Thus, it is a very successful 
skeleton for regeneration. In addition, the coronal pulp removed in regenerative 
pulpotomy procedures can be replaced with PRF to cover the underlying live pulp. 
Then it is covered with mineral trioxide aggregate (MTA). PRFs are also included 
in the apical surgery in the endodontic field. In this field, there are authors who 
say that the PRFs are successful, as well as the authors who say that the PRFs did 
not make a significant change. PRFs are thought to be mixed with MTA to create 
root end barrier. In order to fill the bone cavities formed after apical surgery, good 
results can be obtained by mixing the bone grafts and PRF [55–59].
10. Usıng PRFs ın perıodontology
In the field of periodontology, PRFs are used in the treatment of gingival 
recessions, intra-bone defects, furcation defects, wound healing of hard and soft 
tissues, and regeneration of all periodontium tissues. Growth factors used in the 
periodontium tissues achieve their therapeutic and regenerating properties of 
tissues by providing differentiation and proliferation inducing effects such as angio-
genesis, cementogenesis, differentiation of osteoblasts, anabolic bone formation, 
etc. Compared with traditional periodontal treatments, it is seen that PRF systems 
provide very useful results thanks to these properties [60–62].
In addition to periodontal flap applications in teeth with intra-bone defects, 
successful results are obtained by providing regeneration in hard and soft tissues in 
the region related to PRF applications. With the use of PRF in intra-bone defects, 
a decrease in pocket depth scores, an increase in clinical attachment level, and an 
increase in bone filling of the region are observed, and significant advantages are 
observed as a result of use alone or in combination with other biomaterials [63, 64].
15
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As with intra-bone defects, PRF applications in furcation defects provide 
successful results with applications combined with traditional periodontal flap 
operations. Studies showed that the coronally advanced flap procedure gives more 
successful results when applied in combination with free connective tissue graft or 
PRF. Therefore; PRF applications are seen as an alternative to free tissue grafts in 
periodontal treatments [63, 64].
The use of PRF has been shown to have successful results in patients with 
aggressive periodontitis. As a result of the combined applications of PRF systems 
with traditional periodontal surgery, an increase in the level of attachment, 
decrease in pocket depth and long-term follow-up bone regeneration can be 
observed in the teeth with aggressive periodontitis [65].
When it comes to gingival recessions, coronally advanced flap procedure with 
subepithelial connective tissue are among the first periodontal treatments that 
come to mind. With the widespread use of PRF, the use of PRF instead of subepi-
thelial connective tissue graft is still an area in which studies are ongoing. Compared 
to the subepithelial connective tissue, it does not create a donor site wound, healing 
process and preventing patient discomfort during this process are the most impor-
tant advantages of PRF applications in this area [66, 67].
Another use of PRF membranes in periodontology is that it can be used as a 
palatal wound bandage or protective membrane after placement of connective 
tissue grafts. Studies show that it is an effective method to protect the newly formed 
wound area in palatina and to increase patient comfort by accelerating wound heal-
ing in the area [68, 69].
PRF applications are among the most up-to-date and promising areas of peri-
odontology due to their versatile nature. PRFs can be applied alone to the defect 
surfaces, as well as combined with graft materials or can serve as a thin membrane 
in regenerative treatments. In addition to these features, they have the feature of 
being an alternative to connective tissue grafts, thanks to their cellular content, 
when appropriate. In addition to the aforementioned areas of use, they can function 
as wound plugs and provide graft stabilization. Considering all these, with its low 
cost and biological features, PRF applications are effective in many areas in peri-
odontology [63, 64].
11. Conclusıon
In many studies, successful results have been obtained from PRFs. It can be said 
that the most important reason for PRFs success is the growth factors in its own 
structure. The accelerator and strengthening effect of wound healing is quite obvi-
ous with their effect. Besides, it is seen that PRFs have positive effects in regenera-
tion and augmentation procedures. Although more studies are needed on the use 
of PRFs in some specific areas, PRFs are used quite frequently. In the future, their 
use seems to increase in all fields of dentistry especially in oral and maxillofacial 
surgery.
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